• A multicentre RCT in venous leg ulcers and pressure ulcers, to compare SILVERCEL ® with control (ALGOSTERIL ® , a calcium alginate dressing) to minimize risk of local infection, in 99 patients, over 4 weeks
• The wound severity score for the test group was signifi cantly reduced after 4 weeks treatment (-32+/-17% versus -23+/-25%, p=0.034)
• The 4-week closure rate was signifi cantly greater in the test group (0.32+/-0.57cm2/day versus 0.16+/-0.40cm2/day; p=0.024)
STUDY OBJECTIVE
To evaluate the clinical impact of SILVERCEL ® (a silver-releasing hydroalginate) to minimize the risk of local infection in colonized chronic wounds compared to an alginate control (ALGOSTERIL ® ). 
METHODS

Randomised
RESULTS
The total mASEPSIS score* over 14 days was not significantly different between groups (p=0.791). While the score was lower in the test group for pressure sores, the reverse was found in leg ulcers. This was thought to be due to low sensitivity of the scoring system and the heterogeneity of chronic wounds.
During the study period no significant difference in use of systemic antibiotics was observed between groups, however significantly fewer patients that completed the 4-week study duration were treated with systemic antibiotics at final visit (p=0.053); Control = 4/38 (10.5%) & Test group = 0/40 (0%). Also fewer wounds developed a clinical infection in the 4-week follow-up period in the test group (33% vs. 46%; p=0.223).
Compared to baseline, the absolute decrease in wound severity score at week 4 was higher in the test group (-5.6+/-3.2 versus -4.1+/-4.3; p=0.063); this was also true for percentage reduction (32 +/-17% vs. 23 +/-25%; p=0.034).
The global wound areas did not differ significantly for each of the 2 wound types; however, the surface area of VLUs was on average larger in the test group (44.8+/-46.3cm2 versus 24.5+/-21.3cm2). To account for this difference, closure rate was calculated. Overall the 4-week closure rate was significantly greater in the test group (0.32+/-0.57cm2/day versus 0.16+/-0.40cm2/day; p=0.024). The SILVERCEL ® dressing was well tolerated; poor dressing tolerability was recorded as 10.4% in the control group and 9.8% in the test group.
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CONCLUSIONS
This study suggests that the use of SILVERCEL ® (a silver hydroalginate dressing) in wounds at high risk of infection may have a clinically favourable influence on wound prognosis.
* The ASEPSIS system is a quantitative scoring method to quantify postoperative wound infections and evaluate the effectiveness of antibiotic prophylaxis prior to cardiac surgery. The score is calculated using objective criteria based both on visual characteristics of the wound and the consequences of infection. Points are given if there is need for Additional treatment, the presence of Serous discharge, Erythema, Purulent exudate, and Separation of the deep tissues, the Isolation of bacteria; and duration of inpatient Stay (ASEPSIS).
